Search

Search Constraints

You searched for: Author/Creator Hagmann, Henning

Search Results

1. Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia. Issue 4 (October 2020)

3. Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane. Issue 4 (13th January 2014)

4. Circulating Maternal sFLT1 (Soluble fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse Model. Issue 4 (15th August 2021)

5. Circulating Maternal sFLT1 (Soluble fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse Model. Issue 4 (October 2021)

6. First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy. (29th September 2021)

7. Inhibition of insulin/IGF‐1 receptor signaling protects from mitochondria‐mediated kidney failure. Issue 3 (2nd February 2015)

9. Maternal sFLT1 is sufficient to impair spiral arterial remodeling in mice: the link from placental dysfunction to maternal preeclampsia?. (1st September 2021)

10. Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis. (30th November 2020)